TTUHSC School of Pharmacy
HomeSOPFaculty & Staff Directory

Faculty & Staff Details

Profile for Gary Jean, Jr PharmD

Gary Jean

Gary Jean, Jr PharmD

  • Assistant Professor Pharmacy Practice Dal
Office Phone: 214-358-9021
Mail Address: 5920 Forest Park Rd Ste 400
Dallas TX 75235-6418


Gary Jean, Pharm.D., BCOP is an Assistant Professor in the Department of Pharmacy Practice at Texas Tech University Health Sciences Center School of Pharmacy. He received his Pharm.D. from the Texas Tech University Health Sciences Center School of Pharmacy, and completed a Pharmacy Practice Residency at the North Texas VA Medical Center and Specialty Residency in Hematology/Oncology at the North Texas VA Medical Center in conjunction with TTUHSC-SOP. His practice specialty is hematology/oncology. Dr. Jean's research interests include pharmacoeconomic, access to care in indigent populations, and supportive/palliative care.

Selected Publications:

  • La-Beck I, Jean G, Huynh C, Alzghari SK, Lowe D. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy. Pharmacotherapy 2015;35(10):963-967.
  • Jean GW, Comeau JM. Role of obinutuzumab in the treatment of chronic lymphocytic leukemia. American Journal of Health System Pharmacy 2015;72(11):933-42.
  • Barman SL, Jean G, Dinsfriend WM, Gerber DE. Choroid plexus papilloma-A case highlighting the challenges of extrapolating pediatric chemotherapy regimens to adult populations.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2014.
  • Hall RG, Jean G, Sigler M, Shah SR. Dosing considerations for obese patients receiving cancer chemotherapeutic agents.. The Annals of pharmacotherapy 2013;47(12):1666-74.
  • Devarakonda SS, Shahan JL, Takalkar A, Chaudhery SI, Jean G, Koshy NV, Heldebrandt GC. Graft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity conditioning allogeneic hematopoietic cell transplant. Leukemia & Lymphoma 2013;54(11):2545-7.